IBDEI16L ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19166,0)
 ;;=J45.52^^64^851^30
 ;;^UTILITY(U,$J,358.3,19166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19166,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,19166,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,19166,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,19167,0)
 ;;=J45.50^^64^851^31
 ;;^UTILITY(U,$J,358.3,19167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19167,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19167,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,19167,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,19168,0)
 ;;=J43.0^^64^851^32
 ;;^UTILITY(U,$J,358.3,19168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19168,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,19168,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,19168,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,19169,0)
 ;;=J45.901^^64^851^3
 ;;^UTILITY(U,$J,358.3,19169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19169,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,19169,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,19169,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,19170,0)
 ;;=J45.902^^64^851^4
 ;;^UTILITY(U,$J,358.3,19170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19170,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,19170,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,19170,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,19171,0)
 ;;=J45.909^^64^851^5
 ;;^UTILITY(U,$J,358.3,19171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19171,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,19171,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,19171,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,19172,0)
 ;;=J42.^^64^851^13
 ;;^UTILITY(U,$J,358.3,19172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19172,1,3,0)
 ;;=3^Chr Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,19172,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,19172,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,19173,0)
 ;;=I95.1^^64^852^1
 ;;^UTILITY(U,$J,358.3,19173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19173,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,19173,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,19173,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,19174,0)
 ;;=I73.9^^64^852^2
 ;;^UTILITY(U,$J,358.3,19174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19174,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,19174,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,19174,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,19175,0)
 ;;=I80.13^^64^852^3
 ;;^UTILITY(U,$J,358.3,19175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19175,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
 ;;^UTILITY(U,$J,358.3,19175,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,19175,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,19176,0)
 ;;=I80.213^^64^852^4
 ;;^UTILITY(U,$J,358.3,19176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19176,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Iliac Vein
 ;;^UTILITY(U,$J,358.3,19176,1,4,0)
 ;;=4^I80.213
 ;;^UTILITY(U,$J,358.3,19176,2)
 ;;=^5007833
 ;;^UTILITY(U,$J,358.3,19177,0)
 ;;=I80.223^^64^852^7
 ;;^UTILITY(U,$J,358.3,19177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19177,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Popliteal Vein
 ;;^UTILITY(U,$J,358.3,19177,1,4,0)
 ;;=4^I80.223
 ;;^UTILITY(U,$J,358.3,19177,2)
 ;;=^5007837
 ;;^UTILITY(U,$J,358.3,19178,0)
 ;;=I80.233^^64^852^8
